RL (RL)

$20.7B
Market Cap
23.3
P/E Ratio
1.49
Beta
1.06%
Dividend Yield
Piotroski 7/9Altman Z 6.1 SafeBeneish M -2.76 CleanROIC−WACC +2.4%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 6.1 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company demonstrates robust fundamental quality, evidenced by a 16.0% ROIC that generates a +2.4% spread over its cost of capital, indicating efficient value creation relative to financing costs. The DuPont decomposition reveals an equity multiplier-driven return on equity of 28.7%, where leverage (2.72x) amplifies strong operating performance rather than being the sole engine; this is supported by healthy net margins at 10.5% and solid asset turnover. Financial integrity metrics further validate these fundamentals, with a Piotroski F-Score of 7/9 signaling financial strength, an Altman Z-Score of 6.1 suggesting low bankruptcy risk, and a Beneish M-Score of -2.76 indicating minimal likelihood of earnings manipulation.

Valuation analysis presents a divergence between current market pricing and intrinsic value models. Trading at a forward P/E of 23.3x, the stock appears priced above its DCF-derived fair value of $179, implying that the market is anticipating growth rates exceeding those embedded in the discount model's assumptions for future cash flows. While revenue grows at a steady 6.8% year-over-year, sustaining this trajectory to justify the premium multiple will require execution consistent with high-margin operations and disciplined capital allocation.

Risk assessment highlights a notable divergence from insider sentiment relative to the company's strong balance sheet metrics. Despite the favorable Piotroski score and low distress probability indicated by the Altman Z-Score, insiders have executed $17 million in net selling over the past 90 days. This activity warrants scrutiny as it contrasts with the otherwise sound operational profile, potentially signaling management concerns about near-term headwinds or a belief that shares are currently undervalued relative to long-term prospects.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.6%13.6%15.6%
2%$205$168$141
3%$223$179$149
4%$246$193$158

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.6%, terminal growth 3%. Fair value $179 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
6.1
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.76
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

68.5%
Gross Margin
10.5%
Net Margin
16.0%
ROIC
13.6%
WACC
ROIC − WACC Spread: +2.4%— Positive spread.
+6.8%
Revenue Growth (YoY)
+14.9%
Earnings Growth (YoY)
1.0B
Free Cash Flow
20%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

10.5%
Net Profit Margin
NI ÷ Revenue
×
1.00x
Asset Turnover
Revenue ÷ Assets
×
2.72x
Equity Multiplier
Assets ÷ Equity
=
28.7%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.72x
Debt / Equity
1.78x
Current Ratio
22.6x
Interest Coverage
-1.0x
Net Debt / EBITDA
5.21%
FCF Yield
1.2B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$17M
Net Selling
0
Buy Transactions
2
Sale Transactions
2026-03-04ALAGOZ HALIDESold 4/8 qtrsSale$405,440
2026-02-10LOUVET PATRICESold 4/8 qtrsSale$17M
2026-01-09AHRENDTS ANGELA J COUCHGrant1 shares
2026-01-09GEORGE MICHAEL AGrant1 shares
2026-01-09JARRETT VALERIEGrant1 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $2.04
Act: $2.27
+11.3%
Q3
✓ Beat
Est: $3.50
Act: $3.77
+7.8%
Q2
✓ Beat
Est: $3.45
Act: $3.79
+9.9%
Q1
✓ Beat
Est: $5.81
Act: $6.22
+7.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

19.0
Forward P/E
PEG Ratio
7.17
Price/Book
612606
Avg Volume
$389.15
52W High
$176.61
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.5B
Tracked Passive Exposure
8
ETFs Holding RL
0.04%
Avg Weight in ETFs
$4.0T
Total ETF AUM

When investors buy or sell ETFs like VFQY or XLY, the fund manager is mechanically forced to buy or sell RL shares regardless of RL's individual fundamentals. We estimate $1.5B of passive capital is structurally linked to RL through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in RL to visualize passive redemption contagion across ETFs and collateral stocks.

RL Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
RLEpicenterVOOETFIVVETFSPYETFAMZNLow RiskAMZNLow RiskTSLALow RiskTSLALow RiskHDLow Risk
RL Price Drop (%)0

If RL (RL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies AMAZON.COM INC (AMZN) as the most exposed collateral stock, sharing 2 ETFs with RL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 28 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

RL Ownership Dynamics

Ticker
RL

Float lock-up computed from 28 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

RL Capital Efficiency

How efficiently does RL convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.0B
EBITDA
$1.2B
FCF Conversion
84%
Reinvestment Rate
16%
84% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
16.0%
ROIC − WACC Spread
2.4%

RL converts 84% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 2.4% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-052,955$354.29$1.0M
2026-04-273$371.24$1,113.72
2026-04-2057$386.88$22,052.16
2026-04-15267$373.00$99,591
2026-04-1330$379.87$11,396.1
2026-04-063,605$348.02$1.3M
2026-03-30191$327.82$62,613.62
2026-03-26538$345.93$186,110.34
2026-03-254$343.50$1,374
2026-03-2033$340.21$11,226.93
2026-03-1960$341.62$20,497.2
2026-03-1861$349.21$21,301.81
2026-03-17836$339.24$283,604.64
2026-02-234$385.03$1,540.12
2026-02-1841,604$370.50$15.4M
2026-02-17477$369.18$176,098.86
2026-02-044,575$354.04$1.6M
2026-02-022,475$353.41$874,689.75
2026-01-12939$369.81$347,251.59
2026-01-0812$360.94$4,331.28
2025-12-29387$358.11$138,588.57
2025-12-12153$367.62$56,245.86
2025-12-1111$357.70$3,934.7
2025-11-2818,452$371.22$6.8M
2025-11-202,032$330.88$672,348.16
2025-11-1920$328.26$6,565.2
2025-10-2345$332.12$14,945.4
2025-10-224$334.98$1,339.92
2025-10-21791$333.00$263,403
2025-10-205,033$327.76$1.6M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare RL to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.